Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 42INDUSTRY 4OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Ovarian Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

apatinib 25Cisplatin 19Capecitabine 17Irinotecan 16Cyclophosphamide 16fludarabine 14Radiotherapy 12Oxaliplatin 12Drug Therapy 12camrelizumab 11Paclitaxel 11S 1 (combination) 10Docetaxel 10Carboplatin 10Fluorouracil 9Blood Specimen Collection 9Bevacizumab 9Nivolumab 8tislelizumab 7Radiation 7Pemetrexed 7Gemcitabine 7Erlotinib Hydrochloride 7Surgical Procedures, Operative 6Neoadjuvant Therapy 6Albumin-Bound Paclitaxel 6toripalimab 5anlotinib 5XELOX 5Tamoxifen 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER_GOV × Saline Solution × Clear all
NCT03062059 2022-04-14

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

National Cancer Center, Korea

Phase 2 Unknown
134 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT02711865 2016-03-17

Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer

Hillel Yaffe Medical Center

Unknown
20 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡